Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) announced the presentation of preclinical study data demonstrating that phosphatidylserine (PS)-targeting antibodies similar to bavituximab are able to enhance …
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies and advancing …
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a biopharmaceutical company focused on developing therapeutics to stimulate the body’s immune system to fight cancer, today announced that it …
